hrp0084p3-932 | GH & IGF | ESPE2015
Llop Maria Escola
, Gelonch Raquel Monne
, Cabases Montse Olona
, Navarro Angels Vilanova
, Canhoto Diana Sofia de Melo
, Yuste Encarnacion Torruz
Background: The administration of GH on paediatric patients to optimize the longitudinal growth, can modify some cardiovascular risk factors due to their effects on metabolism.Objective and hypotheses: Evaluation of the effect of GH on total cholesterol blood levels (TCBL), fasting blood glucose concentration (FBGC), blood pressure (BP) and BMI, comparing these variables before starting treatment, after a year and at the end. And it also assesses whether...